Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kathryn B, Bollin"'
Autor:
Christopher A Barker, Evan J Lipson, Harriet Kluger, Brian R Gastman, Michael T Tetzlaff, Igor Puzanov, Shailender Bhatia, Paul Nghiem, Ann W Silk, Zeynep Eroglu, Sunandana Chandra, Isaac Brownell, Anna C Pavlick, David M Miller, Vernon K Sondak, Kari L Kendra, Kathryn B Bollin, Kathleen Madden, Guilherme Rabinowits, Emily S Ruiz, Edward A Tavss
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtyp
Externí odkaz:
https://doaj.org/article/2231699fe22649279195857fb8881112
Autor:
Grace Sora Ahn, Brian Hinds, Frederic Kolb, Amy K. Reisenauer, Seaver L. Soon, Ali R. Sepahdari, Kathryn B. Bollin, Soo J. Park
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe recent addition of immunotherapy as a treatment modality to surgery and radiation has vastly improved disease control for patients with keratinocyte-derived carcinomas (KCs) that are incurable with local therapies alone. With the advent
Externí odkaz:
https://doaj.org/article/4cd31d8dd39e4de9844c4f4187d1ad90
Autor:
Ann W Silk, Christopher A Barker, Shailender Bhatia, Kathryn B Bollin, Sunandana Chandra, Zeynep Eroglu, Brian R Gastman, Kari L Kendra, Harriet Kluger, Evan J Lipson, Kathleen Madden, David M Miller, Paul Nghiem, Anna C Pavlick, Igor Puzanov, Guilherme Rabinowits, Emily S Ruiz, Vernon K Sondak, Edward A Tavss, Michael T Tetzlaff, Isaac Brownell
Publikováno v:
Journal for immunotherapy of cancer. 10(7)
Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtyp
Autor:
Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn, Stephen Capone, Kathryn B Bollin, Daniel Y. Reuben, Keisuke Shirai, Sandy Zhang-Nunes, Omar Ragab, Alicia Terando, Jenny C. Hu, Han Lee, Shailender Bhatia, Sunandana Chandra, Jose Lutzky, Geoffrey Thomas Gibney
Publikováno v:
Journal for immunotherapy of cancer. 10(5)
BackgroundBasal cell carcinoma (BCC) is the most common malignancy worldwide, yet the management of patients with advanced or metastatic disease is challenging, with limited treatment options. Recently, programmed death receptor 1 (PD-1) inhibition h
Autor:
Kathryn B. Bollin, Morganna L. Freeman
Publikováno v:
Translational Cancer Research. 6:3-16
Publikováno v:
Cancer. 124(13)
The rate of advances in uveal melanoma has not kept pace with the rate of advances in cutaneous melanoma. Many patients lack access to or knowledge of specialty centers, and integrated multidisciplinary care between ophthalmology, radiation oncology,
Publikováno v:
Expert Opinion on Orphan Drugs. 1:539-547
Introduction: Myelofibrosis (MF) is a myeloid malignancy that may arise de novo as primary MF or antecedent to essential thrombocythemia or polycythemia vera. Recent discoveries in the pathogenesis contributing to MF symptoms have led to various targ
Publikováno v:
Mayo Clinic Proceedings. 87:286-289
54-year-old man with a history of benign prostatic hypertrophy, hypothyroidism, and well-controlled insulin-dependent diabetes mellitus secondary to idiopathic pancreatitis presented to our internal medicine consultation clinic. He complained of a lu